PI-88 in Hepatocellular Carcinoma After Hepatectomy
Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of PI-88 to inhibit or reduce tumor
recurrence in patients with hepatocellular carcinoma following hepatectomy.